Home page > English > Vizier Project > Vizier News The first VIZIER Scientific and Industrial Conference

 

The first VIZIER Scientific and Industrial Conference

A unique opportunity to be informed about the VIZIER Project, to discover the latest results, to meet with the Consortium scientists, the scientific community, and the other industrial participants.

April 27th, 2007, Le Pharo, MARSEILLE (France).

(Friday 17th November 2006)

NEW PROGRAM

Final Program

-  08:30-08:50 Welcome by the organizers and JF Mattéi (former French Health Minister)

-  08:50-09:30 Applied virology, Dr. E. Gould, VIZIER (UK)

-  09:30-10:50 Respiratory Viruses session [Chairman J. Mesters, VIZIER (G)]

  • 09:30- 09:50 Potential therapeutic targets for Human Coronaviruses, J. Ziebuhr, Univ Belfast (UK)
  • 09:50- 10:10 Development of Antivirals against RSV, P. Najarro, Arrow Therapeutics Ltd (UK)
  • 10:10- 10:50 Resistance of influenza virus to antiviral drugs, B. Lina, VIRGIL (F)

-  10:50-11:20 Coffee Break

-  11:20-12:20 Emerging Viral Diseases session [Chairman X. de Lamballerie, VIZIER (F)]

  • 11:20-11:40 Molecular mecanisms of pathogenicity and interspecies transmission of Avian Influenza Virus, H. Klenk, Marburg Inst (G)
  • 11:40-12:00 Epidemiology of Chikungunya viral disease, A. Flahaut, Ecole HESP (F)
  • 12:00-12:20 Worldwide hot spots for emerging diseases/environmental determinants, J. Carver, ICAV consortium coordinator (Can)

-  12:20-14:00 Lunch-cocktail around the posters and exhibitors.

  • (13:00-14:00 Press conference)

-  14:00-16:00 Hepatitis session [Chairman W. Spaan, VIZIER (ND)]

  • 14:00- 14:20 Epidemiology of Hepatitis, H. Norder, VIZIER (S)
  • 14:20- 14:40 In vitro hepatitis C virus replication mecanisms, R. Bartenschlager, Med Univ Heidelberg (G)
  • 14:40- 15:20 Hepatitis C virus polymerase inhibitors, R. de Francesco, Merck (I)
  • 15:20- 16:00 Hepatitis C virus protease inhibitors, O. Lenz, Tibotec (B)

-  16:00-16:30 Coffee Break

-  16:30-17:50 Hemorrhagic Fevers session [Chairman H. Norder, VIZIER (S)]

  • 16:30-16:50 Epidemiology of hemorrhagic fevers, R. Charrel, VIZIER (F)
  • 16:50-17:10 Molecular mecanisms of protein expression of Arenaviruses, S. Gunther, BNInstitute (G)
  • 17:10-17:50 Dengue Antiviral drugs: status and outlook, S. Vasudevan, Novartis (Sing)

-  17:50-18:00 Concluding remarks by Dr Bruno Canard

-  Visit of the exhibitors up to 19h.

Registration Fees (Include coffee breaks and lunch)

Type of participation Registration (after March 15th) Early registration (before March 15th)
Regular 110 90
Student 60 50

Online registration is now available (click here).

The Online payment methods available, are:
-  CB, visa card, mastercard
-  Bank Transfer
-  Check (for French residents only)
-  Order Form (for French residents only)

Seating is limited, do not hesitate to register early.

Contact & registration: Fabrice Malergue

vip@afmb.univ-mrs.fr

+33 6 77 13 40 03

Postscript

 

Final Program, p1
Scientific Advisory Board, p2
Organizations supporting the event, p3
Online Registration, p4
Access to the meeting place, p5
Accommodation, p6

In the same section

VIZIER internal Training Course on Global Phasing Software

VIZIER / SPINE2 Workshop on Structural Virology

The 6th biannual EMBO practical workshop on protein expression, purification and crystallization (PEPC6)

MeDor (Metaserver of Disorder)

Special issue of CPPS on the VIZIER workshop on the definition of protein domains and their likelihood of crystallization.

Report on the VIZIER Molecular Virology Course 2007

EMBO workshop on RNA viruses: replication, evolution and drug design

2nd EMBO Practical Course on High-throughput Protein Production and Crystallization

VIZIER meeting (24months) in Leuven

... Back ... Feedback Contact Back ...